New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
12:16 EDTAPKT, SONS, ORCL, HUM, GCI, CYBX, BRO, YOKU, CSOn The Fly: Midday Wrap
Stocks on Wall Street were sharply lower at midday, with the major averages giving back most or all of Friday's gains. The indices began the session deep in negative territory and remain that way near the lunch hour. There was little on the domestic economic calendar to account for the weakness, but some market participants were attributing the move to profit-taking following a strong start to the year along with political concerns resurfacing in Europe... ECONOMIC EVENTS: In the U.S., the ISM New York area reading of 56.7 was ahead of the expected reading of 53.0. A separate report showed factory orders increased 1.8% in December, versus an expected increase of 2.3%. In Europe, Spanish and Italian government bond yields rose following political developments in both countries. Spain's opposition Socialist Party called on Prime Minister Mariano Rajoy to resign over a corruption scandal, while in Italy former PM Silvio Berlusconi's popularity is seeing a resurgence, which may threaten the reforms implemented by the outgoing government. In Asia, a report over the weekend showed China's non-manufacturing PMI ticked up to 56.2 from 56.1 last month... COMPANY NEWS: Shares of Acme Packet (APKT) surged 22.2% and traded at the $29.25 price it agreed to in a deal to be acquired by Oracle (ORCL). Several companies offering solutions in the same technology area advanced as well, particularly Sonus Networks (SONS), which climbed over 13%. Meanwhile, Oracle slid a bit more than 2% following the deal announcement... Among companies reporting earnings this morning, Humana (HUM) advanced while Gannett (GCI) declined... MAJOR MOVERS: Among the notable gainers was Cyberonics (CYBX), which rallied 8% after a former employee dropped a lawsuit against the company. Also higher were shares of Brown & Brown (BRO), which rose 5.5% after it reported quarterly results after the bell Friday and was upgraded to Outperform at Raymond James this morning. Among the noteworthy losers were Youku Tudou (YOKU), which fell over 6% after Maxim downgraded shares to a Sell rating, and Credit Suisse (CS), down nearly 6% as well following an initiation of coverage with a Hold rating at Canaccord... INDICES: Near noon, the Dow was down 139.75, or 1.00%, to 13,870.04; the Nasdaq was down 41.09, or 1.29%, to 3,138.01; and the S&P 500 was down 15.94, or 1.05%, to 1,497.23.
News For APKT;SONS;ORCL;HUM;GCI;CYBX;BRO;YOKU;CS From The Last 14 Days
Check below for free stories on APKT;SONS;ORCL;HUM;GCI;CYBX;BRO;YOKU;CS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
07:05 EDTYOKUYouku Tudou announces up to $300M share repurchase program
Subscribe for More Information
August 26, 2014
17:33 EDTORCLOracle initiated with a Neutral at DA Davidson
Subscribe for More Information
August 25, 2014
11:11 EDTYOKUOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD ITMN AEO DKS WUBA URBN SPLS YOKU GME
August 22, 2014
13:49 EDTORCLOregon sues Oracle over health exchange website
Subscribe for More Information
11:26 EDTORCLSalesforce.com rallies following beat and raise quarter
Subscribe for More Information
10:06 EDTYOKUOptions with decreasing implied volatility
Options with decreasing implied volatility: AMPE FOLD GME YOKU SPLS DKS WUBA ARWR ACHN
10:01 EDTCYBXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:13 EDTCYBXCyberonics downgraded at Canaccord
Subscribe for More Information
06:20 EDTCYBXCyberonics downgraded to Hold from Buy at Canaccord
Subscribe for More Information
August 21, 2014
07:11 EDTCYBXCyberonics sees FY15 EPS $2.33-$2.39, consensus $2.36
Subscribe for More Information
07:09 EDTCYBXCyberonics reports Q2 adjusted EPS 53c, consensus 55c
Reports Q2 revenue $72M, consensus $74.05M; Reports Q2 international sales $13.2M, Q2 U.S. sales $58.8M.
August 20, 2014
14:15 EDTYOKUFollow-up: Youku Tudou downgraded to Equal Weight at Morgan Stanley
Subscribe for More Information
14:11 EDTYOKUYouku Tudou downgraded to Equal Weight from Overweight at Morgan Stanley
07:19 EDTYOKUYouku Tudou price target lowered to $24 from $27 at Brean Capital
Subscribe for More Information
August 19, 2014
18:07 EDTYOKUYouku Tudou sees Q3 revenue RMB 1.09B-RMB 1.13B
Subscribe for More Information
18:06 EDTYOKUYouku Tudou reports Q2 EPS (RMB 0.88) vs. (RMB 0.63) last year
Reports Q2 revenue RMB 958.72M vs. RMB 753.46M.
15:16 EDTYOKUNotable companies reporting after market close
Subscribe for More Information
12:51 EDTYOKUYouku Tudou technical comments ahead of results
In the prior three months the stock has been nearly flat in trading, punctuated by a few upside moves that failed to hold. A key level for the stock on the downside is at the $19 area. This has been support in the interval, and might well be tested again on a disappointment in expectations. If the $19 area breaks, the 52-week low at $17.77 would be the next likely downside objective. On a positive surprise, the $24 area is key. This has been the range high in the last three months. A move that is not strong enough to break above this level would keep the shares range bound. A breakout above, especially when viewed on a longer-term chart, would turn the longer-term trend back to bullish from neutral. Shares have been consolidating in price, basing, for the past several months. Resistance above $24 would be at $25.02. There is a large short-base in the name at 8.6% of the float short. That could add to buy-to-cover demand on a positive surprise.
August 18, 2014
15:07 EDTYOKUYouku Tudou August weekly 22 straddle priced for 8.5% move into Q2
11:24 EDTYOKUYouku Tudou downgraded to Hold from Buy at TH Capital
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use